Charles Schwab Investment Management Inc. Purchases Shares of 139,616 Septerna, Inc. (NASDAQ:SEPN)

Charles Schwab Investment Management Inc. purchased a new stake in shares of Septerna, Inc. (NASDAQ:SEPN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 139,616 shares of the company's stock, valued at approximately $3,197,000. Charles Schwab Investment Management Inc. owned about 0.31% of Septerna as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of SEPN. Bank of New York Mellon Corp acquired a new position in Septerna in the 4th quarter valued at $872,000. New York State Common Retirement Fund bought a new stake in Septerna during the fourth quarter valued at about $32,000. Rhumbline Advisers acquired a new stake in shares of Septerna in the fourth quarter valued at about $458,000. Finally, SG Americas Securities LLC bought a new position in shares of Septerna in the fourth quarter worth about $185,000.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on SEPN shares. Cantor Fitzgerald restated an "overweight" rating and set a $50.00 target price on shares of Septerna in a research note on Tuesday, February 11th. Wells Fargo & Company reduced their price objective on Septerna from $14.00 to $11.00 and set an "equal weight" rating for the company in a research report on Friday.

Insider Buying and Selling

In related news, Director Alan Ezekowitz bought 41,355 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The stock was acquired at an average price of $6.00 per share, for a total transaction of $248,130.00. Following the transaction, the director now directly owns 104,101 shares of the company's stock, valued at $624,606. This represents a 65.91 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Gil M. Labrucherie purchased 10,500 shares of the firm's stock in a transaction that occurred on Wednesday, February 19th. The stock was bought at an average cost of $5.51 per share, for a total transaction of $57,855.00. Following the purchase, the chief financial officer now owns 10,500 shares in the company, valued at $57,855. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 74,346 shares of company stock valued at $439,670 over the last ninety days.

Remove Ads

Septerna Stock Performance

Shares of NASDAQ SEPN traded down $0.31 during mid-day trading on Monday, hitting $5.79. The company had a trading volume of 374,983 shares, compared to its average volume of 461,937. Septerna, Inc. has a 12 month low of $4.17 and a 12 month high of $28.99. The firm's 50-day moving average price is $9.73.

Septerna (NASDAQ:SEPN - Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The company reported ($0.64) EPS for the quarter, topping analysts' consensus estimates of ($0.69) by $0.05. The firm had revenue of $0.21 million during the quarter, compared to the consensus estimate of $0.13 million. Research analysts forecast that Septerna, Inc. will post -7.11 earnings per share for the current fiscal year.

About Septerna

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.